Loading organizations...
Yunion Healthcare Ventures operates as a specialized venture capital firm, primarily focused on strategic investments within the healthcare and life sciences sectors. The firm’s core offering involves providing early-stage capital, particularly at the Series A level, to promising startups. It distinguishes itself as a research-oriented fund, applying a deep analytical approach to identify and support companies developing innovative solutions and technologies in the medical and biological fields within China.
Established in 2019, Yunion Healthcare Ventures was formed with an understanding of the significant growth and innovation potential within the Chinese healthcare market. Its inception was driven by a collective insight into the need for specialized capital to nurture nascent life sciences companies, supported by cornerstone limited partners from the top pharmaceutical industry players. This foundation reflects a blend of financial acumen and profound sector-specific knowledge.
The firm's focus is on supporting a diverse portfolio of healthcare and life sciences companies in China, enabling them to bring novel therapies and technologies to market. Yunion Healthcare Ventures envisions a future where its strategic investments accelerate the development of groundbreaking medical advancements, ultimately enhancing patient outcomes and fostering a robust ecosystem of health innovation across the region.
Yunion Healthcare Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $18.0M Pre-Series A in Innovac Therapeutics in September 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2023 | Innovac Therapeutics | $18.0M Pre-Series A | — | TG Sino Dragon Fund, Vision Plus Capital |
| May 19, 2021 | Duality Biologics | $90.0M Series B | YI SHI | Green Pine Capital Partners, Huagai Capital, NRL Capital, Oriza Holdings, WuXi Biologics |